Citations

Showing 10 of 108119 citations.

The Older Americans Act and Family Caregiving: Perspectives from Federal and State Levels
Bangerter, Lauren R. , Fadel, Meghan, Riffin, Catherine , Splaine, Michael

Mayo Clinic

Public Policy & Aging Report | February 27, 2019 | Volume: 29 | Issue: 2 | Pages: 62-66

10.1093/ppar/prz006 | PMID 31205404 Get It

Effect of Trinucleotide Repeat Expansion on the Expression ofTCF4mRNA in Fuchs' Endothelial Corneal Dystrophy
Okumura, Naoki , Hayashi, Ryosuke , Nakano, Masakazu , Yoshii, Kengo, Tashiro, Kei, Blake, Derek J. , Aleff, Ross A., Butz, Malinda L., Highsmith, Edward W., Wieben, Eric D. , Fautsch, Michael P. , Baratz, Keith H. , Komori, Yuya, Nakahara, Makiko , Tourtas, Theofilos , Schlötzer‐Schrehardt, Ursula , Kruse, Friedrich E., Koizumi, Noriko , Aleff, Ross, Butz, Malinda, Hayashi, Ryosuke, Sato, Takahiko

Mayo Clinic

Investigative Opthalmology & Visual Science | February 27, 2019 | Volume: 60 | Issue: 2 | Pages: 779

10.1167/iovs.18-25760 | PMID 30811544 Get It

Vehicle Restraint Considerations for Commercial Spaceflight
Speicher, Leigh L. , Vanderploeg, James M., Blue, Rebecca S.

Mayo Clinic

New Space | February 27, 2019 | Volume: 7 | Issue: 1 | Pages: 3-11

10.1089/space.2018.0026 Get It

Abstract There are currently no direct regulations and few guidelines regarding restraint design for commercial spaceflight vehicles. Operators designing vehicles intended solely for private commercial use, particularly short-duration suborbital flights, have questioned the need for 5-point restraints, instead considering the options of fewer restraints and less stringent application requirements. We sought to identify risks and benefits of alternative restraint designs for the commercial spaceflight industry, particularly for the diverse population of commercial spaceflight participants (SFPs). A systematic review was conducted on currently available information and published literature of human and animal studies as well as industry standards regarding restraint design, common injuries, and patterns of injuries in vehicular trauma, including automobile, aircraft, and spacecraft. Although data are lacking regarding commercial spacecraft or potential mishap forces, extensive studies are available in analogue environments, including motor vehicle crashes and aviation mishaps, which demonstrate variations of restraint design and relative risks and benefits of these systems. These studies demonstrate superiority of harnesses that include shoulder restraint and a negative-G (crotch) belt to limit torso movement. Injury patterns in anthropometrically varied populations, with factors including gender, obesity, and advanced age, demonstrate increased vulnerability to morbidity and mortality in obese and elderly populations and improved outcomes with more rigorous restraint designs. Given the varied population anticipated for commercial SFPs and significant reduction in morbidity and mortality associated with 5-point restraint designs, evidence suggests that the use of a 5-point restraint is most appropriate for commercial spacecraft.
The colorful landscape of multiple myeloma
Muchtar, Eli , Gertz, Morie A. , Gertz, Morie A , Muchtar, E

Mayo Clinic

Leukemia & Lymphoma | February 27, 2019 | Volume: 60 | Issue: 9 | Pages: 2099-2100

10.1080/10428194.2019.1585842 | PMID 30810426 Get It

A Proposal to Add a New Dedicated Chapter in ICD-11: Disorders Related to Chronic Pain
Cheng, Jianguo , Han, Ji-Sheng, Gallagher, Rollin M., Fan, Bifa , Liu, Yanqing , Stanos, Steven P., Lamer, Tim J. , Zhang, Daying , Fu, Zhijian , Yi, Xiaobin , Liu, Xiaoli , Ma, Ke , Jin, Yi, Yang, Xiao-Qiu, Huang, Dong , Xiao, Lizu, Feng, Zhi-Ying, Cheng, Zhixiang , Lü, Yan , Song, Xue‐Jun , Yu, Shengyuan , Jin, Yi, Feng, Zhi-Ying

Mayo Clinic

Pain Medicine | February 27, 2019 | Volume: 21 | Issue: 3 | Pages: 436-438

10.1093/pm/pnz060 | PMID 30953586 Get It

A multi-institutional analysis of presentation and outcomes for leptomeningeal disease recurrence after surgical resection and radiosurgery for brain metastases
Prabhu, Roshan S. , Turner, Brandon E. , Asher, Anthony L. , Marcrom, Samuel , Fiveash, John B. , Foreman, Paul M. , Patel, Kirtesh R., Curran, Walter J. , Breen, William G. , Brown, Paul D. , Grills, Inga S., Arden, Jessica D. , Foster, Lauren, Manning, Matthew A., Stern, Joseph D., Soltys, Scott G. , Burri, Stuart H., Turner, Brandon E , Press, Robert H. , Jethwa, Krishan R.

Mayo Clinic

Neuro-Oncology | February 27, 2019 | Volume: 21 | Issue: 8 | Pages: 1049-1059

10.1093/neuonc/noz049 | PMID 30828727 Get It

Abstract Background Radiographic leptomeningeal disease (LMD) develops in up to 30% of patients following postoperative stereotactic radiosurgery (SRS) for brain metastases. However, the clinical relevancy of this finding and outcomes after various salvage treatments are not known. Methods Patients with brain metastases, of which 1 was resected and treated with adjunctive SRS, and who subsequently developed LMD were combined from 7 tertiary care centers. LMD pattern was categorized as nodular (nLMD) or classical (“sugarcoating,” cLMD). Results The study cohort was 147 patients. Most patients (60%) were symptomatic at LMD presentation, with cLMD more likely to be symptomatic than nLMD (71% vs. 51%, P = 0.01). Salvage therapy was whole brain radiotherapy (WBRT) alone (47%), SRS (27%), craniospinal radiotherapy (RT) (10%), and other (16%), with 58% receiving a WBRT-containing regimen. WBRT was associated with lower second LMD recurrence compared with focal RT (40% vs 68%, P = 0.02). Patients with nLMD had longer median overall survival (OS) than those with cLMD (8.2 vs 3.3 mo, P < 0.001). On multivariable analysis for OS, pattern of initial LMD (nodular vs classical) was significant, but type of salvage RT (WBRT vs focal) was not. Conclusions Nodular LMD is a distinct pattern of LMD associated with postoperative SRS that is less likely to be symptomatic and has better OS outcomes than classical “sugarcoating” LMD. Although focal RT demonstrated increased second LMD recurrence compared with WBRT, there was no associated OS detriment. Focal cranial RT for nLMD recurrence after surgery and SRS for brain metastases may be a reasonable alternative to WBRT.
Is the Search for Enough Moderate-Severe Ischemia Nearly Over?
Gibbons, Raymond J.

Mayo Clinic

JAMA Cardiology | February 27, 2019 | Volume: 4 | Issue: 3 | Pages: 203

10.1001/jamacardio.2019.0024 | PMID 30810699 Get It

Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy
Strawn, Jeffrey R. , Mills, Jeffrey A. , Croarkin, Paul E. , Strawn, Jeffrey R

Mayo Clinic

Journal of Child and Adolescent Psychopharmacology | February 27, 2019 | Volume: 29 | Issue: 4 | Pages: 250-255

10.1089/cap.2018.0145 | PMID 30810350 Get It

Objective: To guide clinicians in selecting the “next line” selective serotonin reuptake inhibitor (SSRI) for adolescents with treatment-resistant major depressive disorder, we sought to compare response rates among SSRIs in the Treatment of SSRI-Resistant Depression in Adolescents (TORDIA) study and to jointly model tolerability and efficacy for the specific SSRI comparisons. Methods: Efficacy and tolerability data for paroxetine, citalopram, and fluoxetine were extracted from the TORDIA study. Using a joint bivariate normal likelihood for response and tolerability (based on the maximum implied variance from the 95% credible intervals previously reported for the three SSRIs), a Monte Carlo pseudorandom sample (100,000 draws) was obtained, from which credible intervals, means, posterior tail probabilities, etc. were determined. Joint null hypotheses of no difference in efficacy and tolerability were then evaluated with regard to superiority of each SSRI over the others. Results: No significant differences in response were observed for citalopram compared with fluoxetine ( p = 0.247) or for fluoxetine compared with paroxetine ( p = 0.110), although citalopram trended toward being superior to paroxetine (mean difference: 0.2, p = 0.055). For efficacy–tolerability models, citalopram and fluoxetine were superior to paroxetine ( p = 0.029 and p = 0.022, respectively) but did not differ between each other ( p = 0.146). Conclusions: Joint efficacy–tolerability models suggest that citalopram and fluoxetine were statistically significantly superior to paroxetine while citalopram trended toward superiority over paroxetine in the efficacy model. These findings provide a more granular and practical evidence base for clinicians faced with treatment sequencing decisions in adolescents with SSRI-resistant depression.
Efficacy of Vedolizumab for Refractory Pouchitis of the Ileo-anal Pouch: Results From a Multicenter US Cohort
Gregory, Martin , Weaver, Kimberly N. , Hoversten, Patrick , Hicks, Stephen B., Patel, Devin , Ciorba, Matthew A. , Gutierrez, Alexandra, Beniwal‐Patel, Poonam , Palam, Sowmya , Syal, Gaurav , Christophi, George P. , Raffals, Laura E. , Deepak, Parakkal , Hicks, Stephen Bradley, Raffals, Laura, Deepak, Parakkal , Herfarth, Hans , Barnes, Edward L.

Mayo Clinic

Inflammatory Bowel Diseases | February 27, 2019 | Volume: 25 | Issue: 9 | Pages: 1569-1576

10.1093/ibd/izz030 | PMID 30810748 Get It

Abstract Background and Aims Inflammation of the pouch after ileal pouch-anal anastomosis (IPAA) can significantly impact quality of life and be difficult to treat. We assessed the effectiveness and safety of vedolizumab in Crohn’s disease (CD) of the pouch and chronic antibiotic-dependent or antibiotic-refractory pouchitis. Methods This was a retrospective, multicenter cohort study at 5 academic referral centers in the United States. Adult patients with endoscopic inflammation of the pouch who received vedolizumab were included. The primary outcome was clinical response at any time point. Secondary outcomes included clinical remission, endoscopic response, and remission. Univariate analysis and multivariate analysis were performed for the effect of the following variables on clinical response: fistula, onset of pouchitis less than 1 year after IPAA, younger than 35 years old, gender, previous tumor necrosis factor inhibitor-alpha use, and BMI &gt;30. Results Eighty-three patients were treated with vedolizumab for inflammation of the pouch between January 2014 and October 2017. Median follow-up was 1.3 years (interquartile range 0.7–2.1). The proportion of patients that achieved at least a clinical response was 71.1%, with 19.3% achieving clinical remission. Of the 74 patients with a follow-up pouchoscopy, the proportion of patients with endoscopic response and mucosal healing was 54.1% and 17.6%, respectively. Patients who developed pouchitis symptoms less than 1 year after undergoing IPAA were less likely to respond to vedolizumab, even after controlling for other risk factors. Conclusions Vedolizumab is safe and effective in the management of CD of the pouch and chronic pouchitis. Further studies are needed to compare vedolizumab with other biologic therapies for pouchitis and CD of the pouch.
Onion‐bulb patterns predict acquired or inherited demyelinating polyneuropathy
Tracy, Jennifer A., Dyck, P. James B. , Engelstad, JaNean K., Meyer, Jane E., Klein, Christopher J. , Engelstad, JaNean , Meyer, Jane E.

Mayo Clinic

Muscle & Nerve | February 27, 2019 | Volume: 59 | Issue: 6 | Pages: 665-670

10.1002/mus.26452 | PMID 30810227 Get It

ABSTRACTIntroductionOnion‐bulbs (OB) are concentrically layered Schwann‐cell processes, surrounding nerve fibers, occurring in both inherited and acquired demyelinating polyneuropathies. We investigated whether OB patterns (generalized, mixed, or focal) correlate with acquired or inherited neuropathies.MethodsOne hundred thirty‐one OB‐rich nerve biopsies were graded for OB pattern and inflammation without knowledge of clinical history. We classified inherited (n = 49) or acquired (n = 82) neuropathies based solely on clinical history.ResultsFifty‐one biopsies had generalized (34 inherited vs. 17 acquired, P < 0.001), 54 mixed (48 acquired vs. 6 inherited, P < 0.001), and 26 focal/multifocal (inherited [n = 9], acquired [n = 17]) OB. Inflammation occurred more frequently in acquired (n = 54) than inherited (n = 14) neuropathy (P = 0.004).DiscussionGeneralized OB correlates with inherited neuropathy; mixed OB with acquired. Inflammation occurs more in acquired neuropathy cases. OB patterns are best explained by ubiquitous Schwann‐cell involvement in inherited and multifocal Schwann‐cell involvement in acquired neuropathies and predict the electrophysiology of uniform demyelination in inherited and unequal demyelination in acquired neuropathies. Muscle Nerve 59:665–670, 2019